Skip to main content

Advertisement

SpringerLink
Log in

Adenosine deaminase in saliva as a diagnostic marker of squamous cell carcinoma of tongue

  • Original Article
  • Published:
Clinical Oral Investigations Aims and scope Submit manuscript

Abstract

Tongue cancer is amongst the most common and fatal types of cancers in the world. The abnormalities in purine metabolism are characteristic features of many human tumors. Little is known about the correlation between the activities of key enzymes of purine nucleotide pathway and clinical indicators of tongue cancer invasiveness and aggressiveness. Fifty patients (M: F 25:25; mean age: 55.6 years (range 45-60; SD 1.8)) with diagnosed squamous cell carcinoma of the tongue (test group) and 30 normal subjects (M: F 15:15) without any systemic disease (control group) were recruited after obtaining informed consent. All patients were staged by the TNM classification. Salivary adenosine deaminase (ADA) activity was assessed in cancerous patients (test group) and normal healthy subjects (control group). Statistically significant differences between test and control groups were observed in salivary ADA (P < 0.001). Furthermore, serum ADA levels significantly increased as the disease stage progressed from stage I to stage III of squamous cell carcinoma of the tongue in both genders (P < 0.001). Salivary ADA might be used as a diagnostic tool for early detection of squamous cell carcinoma of tongue.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Lizuka H, Kozumi H, Kamikagi K, Aoyagi T, Miura Y (1981) Two forms of adenosine deaminase in pig epidermis. J Dermotol 8:91–95

    Google Scholar 

  2. Donofrio J, Coleeman MS, Hutton JJ, Daoud A, Lampkin B, Dyminski J (1978) Overproduction of adenosine deoxynucleosides and deoxynucleotides in adenosine deaminase deficiency with severe combined immunodeficiency disease. Clin Invest 62:884–887

    Article  Google Scholar 

  3. Camici M, Tozzi MG, Allergrini S (1990) Purine salvage enzyme activities in normal and neoplastic human tissues. Cancer Biochem Biophy 11:201–209

    Google Scholar 

  4. Sufrin G, Tritsch GL, Mittelman A, Murphy GP (1978) Adenosine deaminase in patients with carcinoma of the bladder. J Urol 119:343–346

    PubMed  Google Scholar 

  5. Guisti G (1974) Enzyme activities. In: Bergmeyer UH (ed) Methods of enzymatic analysis. Chemia, Bergest, pp 1092–1098

    Google Scholar 

  6. Ray I, Sharma R (2002) Dietary regulation of adenosine deaminase activity in stomach, small intestine and spleen of mice. Ind J Biochem Biophys 39:419–421

    Google Scholar 

  7. Franco R, Valenzuela A, Liuis C, Blanco J (1998) Enzymatic and extraenzymatic role of ectoadenosine deaminase in lymphocytes. Immunol Rev 161:27–42

    Article  PubMed  Google Scholar 

  8. Hofbrand AV, Janossy G (1981) Enzyme and membrane markers in leukemia: recent developments. J Clin Pathol 34:254–262

    Article  Google Scholar 

  9. Gierek T, Drada M, Pilch J et al (1987) Adenosine deaminase and purinephosphorylase activities in lymphocytes and red blood cells of patients with carcinoma of the larynx. Auris Nasus Larynx 14:97–100

    PubMed  Google Scholar 

  10. Raczynska J, Jonas S, Krawczinski J (1996) Diagnostic value of adenosine in some liver diseases. Clin Chem Acta 13:151–154

    Article  Google Scholar 

  11. Gocmen E, Tez M, Ozturk S, Koc M, Demirci S (2009) Activities of adenosine deaminase and 5′-nucleotidase in cancereous and non-cancereous human gastric tissues. Bratisl Lek Listy 110:416–418

    PubMed  Google Scholar 

  12. Marques MM, Junta CM, Zárate-Blades CR, Sakamoto-Hojo ET, Donadi EA, Passos GA (2009) Transcriptional response of peripheral lymphocytes to early fibrosarcoma: a model system for cancer detection based on hybridization signatures. Exp Biol Med (Maywood) 234:802–812

    Article  Google Scholar 

  13. Gallo A, Galardi S (2008) A-to-I RNA editing and cancer: from pathology to basic science. RNA Biol 5:135–139

    Article  PubMed  Google Scholar 

  14. Eroglu A, Canbolat O, Demirci S, Kocaoglu H, Eryavuz Y, Akgül H (2000) Activities of adenosine deaminase and 5′-nucleotidase in cancerous and noncancerous human colorectal tissues. Med Oncol 17:319–324

    Article  PubMed  Google Scholar 

  15. Saracoglu U, Guven O, Durak I (2005) Adenosine deaminase and 5′-nucleotidase activities in saliva from patients with oral and laryngeal cancer. Oral Dis 11:323–325

    Article  PubMed  Google Scholar 

  16. Sanfilippo O, Camici M, Tozzi MG, Turriani M, Faranda A, Ipata PL, Silvestriuni R (1994) Relationship between the levels of purine salvage pathway enzymes and clinical/biological aggressiveness of human colon carcinoma. Cancer Biochem Biophys 14:57–66

    PubMed  Google Scholar 

  17. Kocić1 G, Stanojević G, Nagorni A, Branković B, Pavlović1 D, Jevtović1 T (2003) Diagnostic importance of adenosine deaminase activity for progression and invasion of human colon tumors. Med Biol 10:76–78

    Google Scholar 

  18. Kocic G, Vlahovic P, Djordjevic V, Bjelakovic G, Koracevic D, Savic V (1995) Effect of growth factors on the enzymes of purine metabolism in culture of regenerating rat liver cells. Arch Physiol Biochem 103:715–719

    Article  PubMed  Google Scholar 

  19. Balis EM (1985) Adenosine deaminase and malignant cells. Ann NY Acad Sci 451:142–149

    Article  PubMed  Google Scholar 

  20. Bemi V, Tazzini N, Banditelli S, Giorgelli F, Pesi R, Turchi G, Mattana A, Sgarrela F, Tozzi MG, Camici M (1998) Deoxyadenosine metabolism in a human colon-carcinoma cell line (LoVo) in relation to its cytotoxic effect in combination with deoxycoformycin. In J Cancer 75:713–720

    Google Scholar 

  21. Camici M, Turriani M, Tozzi MG, Turchi G, Cos J, Alemany C, Miralles A, Noe V, Ciudad CJ (1995) Purine enzyme profile in human colon carcinoma cell lines and differential sensitivity to deoxycoformycin and 2′-deoxyadenosine in combination. Int J Cancer 17:176–183

    Article  Google Scholar 

Download references

Conflicts of interest statement

None declared.

Author information

Authors and Affiliations

  1. Oral Imaging Center, School of Dentistry, Oral Pathology and Maxillofacial Surgery, Catholic University Leuven, Kapucijnenvoer 7, 3000, Leuven, Belgium

    Balwant Rai

  2. School of Dentistry, Oral Pathology and Maxillofacial Surgery, Catholic University Leuven, Leuven, Belgium

    Jasdeep Kaur

  3. Dept of Periodontology and Oral Imaging Center, School of Dentistry, Oral Pathology and Maxillofacial Surgery, Catholic University Leuven, Leuven, Belgium

    Reinhilde Jacobs

  4. GDC, PGIMS, Rohtak, India

    Suresh Chander Anand

Authors
  1. Balwant Rai
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jasdeep Kaur
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Reinhilde Jacobs
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Suresh Chander Anand
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Balwant Rai.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rai, B., Kaur, J., Jacobs, R. et al. Adenosine deaminase in saliva as a diagnostic marker of squamous cell carcinoma of tongue. Clin Oral Invest 15, 347–349 (2011). https://doi.org/10.1007/s00784-010-0404-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00784-010-0404-z

Keywords

Search

Navigation